Previous Close | 41.04 |
Open | 41.33 |
Bid | 41.69 x 600 |
Ask | 41.80 x 200 |
Day's Range | 40.66 - 42.36 |
52 Week Range | 22.11 - 53.18 |
Volume | |
Avg. Volume | 958,240 |
Market Cap | 2.746B |
Beta (5Y Monthly) | 1.51 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
The consensus price target hints at a 71.8% upside potential for Celldex (CLDX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Celldex (CLDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in Celldex (CLDX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.